Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased expression of MT1E is a potential biomarker of prostate cancer progression

27 Jun 2017

Abstract excerpt

// Rita Demidenko 1 , Kristina Daniunaite 1, 2 , Arnas Bakavicius 2, 3 , Rasa Sabaliauskaite 2 , Aiste Skeberdyte 1, 2 , Donatas Petroska 4 , Arvydas Laurinavicius 4, 5 , Feliksas Jankevicius 2, 5 , Juozas R. Lazutka 1 and Sonata Jarmalaite 1, 2 1 Life Sciences Centre, Vilnius University, Vilnius, Lithuania 2 National Cancer Institute, Vilnius, Lithuania 3 Urology Centre, Vilnius University, Vilnius, Lithuania 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Molecular Biology Techniques and Applications
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28977898
DOI: 10.18632/oncotarget.18683

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased expression of MT1E is a potential biomarker of prostate cancer progressionPMID 28977898Read ↗

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progressionSemantic proximity Read ↗

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read ↗

Molecular Updates in Prostate Cancer.Semantic proximity Read ↗

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer ProgressionSemantic proximity Read ↗

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesSemantic proximity Read ↗

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancerSemantic proximity Read ↗

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationSemantic proximity Read ↗

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingSemantic proximity Read ↗

The cornerstone of early diagnosis and immunotherapy of prostate cancer:screening characteristic genesSemantic proximity Read ↗

TOP2A and PPARGC1A differentiate chromatin regulator-related subtypes for prostate cancer patients undergoing radical prostatectomySemantic proximity Read ↗

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAsSemantic proximity Read ↗

Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.